← Capa | Mercado

MSK and OpenEvidence Unveil Two-Way Integration Linking Epic Workflow and OncoKB

2026-11-04 · Fonte:deep-www.unite.ai-p10

MSK and OpenEvidence Unveil Two-Way Integration Linking Epic Workflow and OncoKB

Memorial Sloan Kettering and OpenEvidence will embed each other's assets — OpenEvidence in MSK's Epic workflow, and MSK's OncoKB knowledge base in OpenEvidence for outside providers.

Memorial Sloan Kettering Cancer Center and OpenEvidence have announced a partnership structured as a two-way integration, unveiled on September 16, 2026. The arrangement pairs OpenEvidence's medical AI platform being embedded into MSK's Epic electronic health record workflow with OncoKB — MSK's precision oncology knowledge base — being integrated directly into OpenEvidence for use by providers beyond the cancer center's own walls.

The clinical-facing half of the deal places OpenEvidence inside the Epic workflow that MSK clinicians already use, surfacing the AI platform at the point of care rather than as a separate tool clinicians must leave their records system to consult. For an institution like MSK, EHR-native placement is the difference between an AI assistant that sits on the periphery and one that operates inside daily oncology practice.

The second half of the arrangement runs outward. OncoKB, MSK's precision oncology knowledge base, will be integrated directly into OpenEvidence, making it available to providers outside MSK. That converts an internal institutional asset into a distributed resource, reaching external clinicians through OpenEvidence's platform rather than remaining confined to MSK's own environment.

The structure of the partnership illustrates a broader pattern in medical AI: platform distribution is being traded for clinical content. OpenEvidence gains a point-of-care foothold inside MSK's Epic workflow, while MSK gains a channel that carries its precision oncology knowledge base to a much wider provider base. Both integrations — AI into the record system, curated knowledge into the AI — were announced as a single package on September 16, 2026.

For medical AI vendors, the deal underlines how clinical-grade distribution now runs through EHR integrations, while for institutions it shows knowledge bases functioning as exportable strategic assets. Each side supplies what the other lacks: workflow access in one direction, curated oncology evidence in the other.

Tags: OpenEvidence · Memorial Sloan Kettering · OncoKB · Epic EHR · Medical AI · Precision Oncology


Leituras relacionadas


萬安算交所 AIXX · AIXX · Exchange verificado · Ir ao mercado